ASIATODAY

BIZ&TECH

Curocell aims to become global CAR-T leader with Rimcato

“Unlike conventional chemical or antibody drugs, CAR-T therapies require development, manufacturing, quality control and logistics to operate as a fully connected system. We believe this approval is meaningful because it marks the first time a Korean company has verified such end-to-end capabilities.”A Korean biotech company has succeeded in developing a CAR..

Hyundai Russia buyback unlikely without war’s end
Hyundai Motor’s prospects for reacquiring its former Russian manufacturing plant appear virtually closed for now, with the company indicating that a return..

previous block

11 12 13 14 15 16 17 18 19 20

next block

Most Read

1

Trump says Iran deal ‘very likely’ as US, Iran fin..

2

Review of the opera “Don Giovanni” conducted by Ri..

3

Samsung Electronics faces final labor talks amid s..

4

Hyundai rolls out revamped commercial truck lineup

5

KAI launches next-gen satellite successfully

6

S-Oil swings to profit as oil prices surge

7

Trump rejects Iran ceasefire response as talks nea..

PEOPLE

“Hallyu ban to be removed quickly”: Hopes of thaw in Seoul-Beijing ties: · “Efforts will be made to remove Hallyu ban quickly”; · SK Group Chairman heads to Japan to soften “WD risk”

PHOTO

Jang Won-young shines as BVLGARI’s holiday muse

S.KOREA

POLITICS

SOCIAL AFFAIRS

WORLD

CHINA

INDIA

OTHERS

ECONOMY

BIZ&TECH

CULTURE

PEOPLE

PHOTO

Address : In-Young Bldg., 34, Uisadang-daero 1-gil, Yeongdeungpo-gu, Seoul

Copyright by ASIATODAY CO., LTD. All rights resereved